Biocom CEO Joe Panetta Appointed to California Institute for Regenerative Medicine's Independent Citizens' Oversight Committee by Governor Jerry Brown
SAN DIEGO, Jan. 13, 2014 /PRNewswire/ -- Biocom, the association for the Southern California life sciences community, announced that its president and CEO, Joe Panetta, has been appointed to the California Institute for Regenerative Medicine's (CIRM) Independent Citizens' Oversight Committee (ICOC) by Governor Jerry Brown.
"This is an opportunity to work alongside patient advocates, researchers and leaders in the biotechnology space to guide the development of experimental medical treatments through regulatory bodies and ultimately to the patient," said Joe Panetta, who will continue serving as president and CEO for Biocom.
Responsibilities of the CIRM 29-member Governing Board include: (1) adopting scientific, medical, ethical, and intellectual property policies; (2) making final decisions on all grant and loan awards; and (3) overseeing the operations of CIRM.
About California Institute for Regenerative Medicine (CIRM)
CIRM was established in November 2004 with the passage of Proposition 71, the California Stem Cell Research and Cures Act. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was overwhelmingly approved by voters, and called for the establishment of an entity to make grants and provide loans for stem cell research, research facilities, and other vital research.
Biocom is one of the largest regional life science associations in the world, representing more than 600 member companies in Southern California. The association focuses on initiatives that position the region's life science industry competitively on the world stage, and on the development and delivery of innovative products that improve health and quality of life. For more information on BIOCOM or the Southern California biotechnology and medical device community, please visit the organization's Web site at http://www.biocom.org or call (858) 455-0300.
Biocom media contact: